The results of the Regulation of Coagulation in Major Orthopedic Surgery Reducing the Risk of DVT and PE (RECORD) studies showed that rivaroxaban is more effective than enoxaparin in the ...

Aims: The objective of this study was to evaluate the cost–effectiveness of rivaroxaban versus the low-molecular-weight heparins (LMWH) enoxaparin and dalteparin for the prevention of venous ...

making it take longer to form a clot and thereby reducing the risk of blood clots in common conditions such as atrial fibrillation and deep vein thrombosis. Doctors may prescribe Xarelto or other ...

Rivaroxaban is indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation • It is used for preventing deep vein thrombosis (DVT), which may ...

There are anticoagulants such as warfarin, heparin, and new oral medications like rivaroxaban and apixaban ... in the management of patients with pulmonary embolism, DVT, and other thrombotic ...